Its INCI name is Copper Tripeptide-3
It can result from increased production of reactive oxygen species (ROS), breakdown of redox balance, diminished bioavailability of nitric oxide (NO) or decreased antioxidant capacity in various tissues
The neurodegenerative course evolved toward a presentation consistent with primary progressive aphasia
Monastral Blue (MB) (Sigma Company, USA) (1.0 ml/kg b.w.) 3 minutes before ethanol treatment
doi: 10.3390/ijms222011128 Summary Keywords non-alcoholic fatty liver disease, short-chain fatty acids, gut microbiota, glycolipid metabolism, therapy Citation Qin X, Chen M, He B, Chen Y and Zheng Y (2025) Role of short-chain fatty acids in non-alcoholic fatty liver disease and potential therapeutic targets